Citrullination, the deimination of arginine residues into citrulline, has been implicated in the aetiology of several diseases. In multiple sclerosis (MS), citrullination is thought to be a major driver of pathology, through hypercitrullination and destabilization of myelin. As such, inhibition of citrullination has been suggested as a therapeutic strategy for MS. Here, in contrast, we show citrullination by peptidylarginine deiminase 2 (PADI2) is required for normal oligodendrocyte differentiation, myelination and motor function. We identify several targets for PADI2, including myelin-related proteins and chromatinassociated proteins, implicating PADI2 in epigenetic regulation. Accordingly, we observe that PADI2 inhibition and its knockdown affect chromatin accessibility and prevent the upregulation of oligodendrocyte differentiation genes. Moreover, mice lacking PADI2, display motor dysfunction and decreased number of myelinated axons in the corpus callosum. We conclude that citrullination is required for oligodendrocyte lineage progression and myelination and suggest its targeted activation in the oligodendrocyte lineage might be beneficial in the context of remyelination.
Introduction
The conversion of a peptidylarginine into a peptidylcitrulline can introduce profound changes in the structure and function of the modified protein. This posttranslational modification, also known as protein citrullination or deimination, is calcium dependent and is mediated by the family of enzymes called peptidylarginine deiminases (PADIs) 1 . Five PADI isozymes (PADI1, 2, 3, 4 and 6) have been identified in mammals, and their expression pattern and function is tissue-specific 2 . Citrullination has been recently shown to play key roles in multiple cellular processes such as inflammatory immune responses 3 , apoptosis 4 , and regulation of pluripotency 5 . In the central nervous system (CNS), PADI2 is the most prevalent expressed PADI and occurs preferentially in oligodendrocytes (OL) and other glial cells 6 . OLs arise at postnatal stages from the differentiation of OL precursor cells (OPCs) and their most prominent function is the formation of the myelin sheath, an electrical insulating layer for the axons, essential for proper neuronal communication and thus CNS function 7 .
PADI2 has been reported to heavily citrullinate myelin binding protein (MBP), a fundamental myelin component. The ratio MBPcit/MBPtotal is high in the first four years of life and similarly in multiple sclerosis (MS), a disease where demyelination occurs 8 . Upon citrullination, MBP arginine residues lack positive charges, thereby having a reduced interaction with the negatively charged lipids. Consequently, citrullinated MBP does not form compact sheaths and the myelin remains immature or becomes unstable 9 . In accordance, transgenic mice overexpressing PADI2 in OL cells display myelin loss 10 . In light of this, PADIs, and in particular PADI2, have been thought to have a detrimental effect in MS and thus an improvement of the disease symptoms can be achieved by inhibiting their actions 11 . Indeed, treatment of a MS mouse model Experimental Autoimmune Encephalomyelitis (EAE) with 2-chloroacetamidine (2-CA), a PADI2 and -4 inhibitor leads to disease attenuation 12 . The improvement on disease progression by 2-CA treatment was not specifically assigned to the lack of PADI activity in OL lineage cells alone but to inhibition of all PADI-expressing cells, including immune cells that play an essential role in the disease development.
Interestingly, however, no changes in disease progression were observed upon EAE induction in PADI2 KO mice 13 . This could point to a possible compensation of PADI2 functions by other PADIs, or to additional functions of PADI2 in EAE disease progression. While citrullination of myelin might play an important role in MS, other proteins such as histone H3 have been found to be citrullinated in MS 14 . Thus, the role of PADI2-mediated citrullination in MS might not be confined to myelin. Furthermore, while the effects of Padi2 overexpression in OL have been characterized, its absence in OL lineage cells has not been further investigated, nor its physiological function in OL lineage cells and its significance for the myelin integrity maintenance. 
Results
Padi2 expression is increased upon OL differentiation. By analyzing our single-cell RNA-Seq dataset of the OL lineage in the adult and juvenile mouse brain 15 , we identified Padi2 as the predominant Padi expressed in OLs (Supplementary Fig. 1a ). Interestingly, Padi2 expression is found in OPCs, increases in committed OL precursors (COPs) and newly formed OLs (NFOLs) and peaks at more mature stages ( Supplementary Fig. 1a) . Surprisingly, we did not observe expression of Padi4, which has been previously suggested to be present in myelin 14, 16 . To further investigate the pattern of expression of Padi2 during OL lineage progression, we cultured OPCs isolated from postnatal day P1-P4 brains of the transgenic mouse line Pdgfra-histone 2b (H2B)-GFP 17 in which GFP expression is under the control of the endogenous Pdgfra promoter locus. GFP+ OPCs were collected with fluorescence activated cell sorting (FACS) to plates and expanded in media containing the growth factors (GFs) bFGF and PDGFAA and differentiated into OLs by removing the GFs for 2 days (Fig. 1a ). Gene expression of the differentiation markers Mbp and Sox10 was upregulated and the progenitor marker Pdgfra was reduced upon GFs removal (Fig.  1b ). In agreement with the single-cell RNA-seq data, Padi2 was expressed in OPCs and it was greatly enhanced upon differentiation ( Fig. 1b and Supplementary Fig. 1b ). To investigate Padi2 expression in the OL lineage in vivo, we isolated OPCs and OLs from the brain of the transgenic mouse line Pdgfra-Cre-loxP-GFP 18 in which all OL lineage cells ex-press the GFP reporter ( Fig. 1c ). GFP+ OPCs were collected with FACS from P1-P4 pups (all GFP+ cells are OPCs since OLs are not formed yet) and GFP+ CD140-OLs were collected with FACS from juvenile (P21) and adult (P60) mice (at this stage GFP+ cells comprise all OL progeny including CD140+ OPCs). As a confirmation of the sorted populations we have assessed the expression of Pdgfra and Mbp as markers for OPCs and differentiated oligodendrocytes, respectively ( Fig. 1d ). Padi2 mRNA was substantially enriched in OLs from both juvenile and adult brains when compared to postnatal OPCs (Fig. 1d) . At the protein level, and in agreement with our gene expression data, we observed a continuous increase in PADI2 protein from P1 to adult in the spinal cord of wild type mice, concomitant with the increase in the OL marker MBP (Fig. 1e ). Thus, PADI2 is rapidly upregulated upon OPC differentiation, suggesting a role of this citrullinating enzyme at this stage of OL lineage progression.
Reduction of PADI2 activity hinders OL differentiation.
In order to investigate whether the increased expression of PADI2 upon OL differentiation has a functional significance, we inhibited PADI activity in the mouse OPC cell line Oli-neu 19 and rat primary OPCs, using Cl-amidine, a pan-inhibitor of PADI enzymes. Strikingly, Oli-neu cells failed to differentiate in the presence of this inhibitor, as observed by the lack of cell branching typical of differentiating OLs shown with CNPase immunostaining (Fig. 2a ). In accordance, gene expression analysis on undifferentiated and differentiated Oli-neu cells treated with Cl-Amidine re-vealed a striking impairment on OPC differentiation. The increase of Mbp, Sox10 and Mog mRNA levels, crucial for proper OPC differentiation, was no longer observed after Cl-Amidine during differentiation ( Fig. 2b) . Interestingly, the expression of the transcription factor (TF) Sox9, required for OL specification 20 and downregulated upon OPC differentiation 15 , was increased upon PADI inhibition ( Fig. 2b ). Similar results were obtained by treating Oli-neu with another PADI-inhibitor 2-CA ( Supplementary Fig. 1c ). Importantly, these effects were also observed in rat OPC primary cultures, where under differentiating conditions, the treatment with Cl-Amidine impaired differentiation as observed by the lower mRNA expression levels of the differentiation markers Mog and Mag (Fig. 2c ).
To investigate whether the effect of PADI inhibitors was due to PADI2 inhibition, we specifically decreased Padi2 mRNA levels in mouse primary FACS OPCs by transfecting cells with siRNA against Padi2 (targeting exon 2). Similar to PADI inhibition, the reduction of Padi2 expression led to a decrease in the mRNA levels of Sox10 and Mog and an increase in Sox9 (Fig. 2d ). Mog mRNA levels were also reduced in Padi2 knockdown conditions after 2-days of differentiation ( Fig. 2d ). Likewise, Padi2 knockdown in Oli-neu cells mimicked the effects of PADI inhibition (Supplementary Fig. 1d ). Thus, our findings indicate that PADI2 is dra-matically increased on the onset of OL differentiation, where it contributes to the transition from an OPC state to a NFOL state.
OLs are reduced in conditional Padi2 knockout mouse lines. To investigate if the observed effects of PADI2 have an impact on OL differentiation and myelin maintenance in vivo, we generated a Padi2 conditional knock-out (cKO) mouse line, Pdgfra-Cre; RCE:loxP; Padi2-/-where Padi2 is not present in any cells derived from Pdgfra+ cells, which include the whole OL lineage. We estimated the number of CC1+ cells per area at P21, in both corpus callosum and in the dorsal funicullus of the spinal cord. In accordance to our results in Oli-neu and primary FACS OPC cultures ( Fig. 2) , we observed a reduction in the number of CC1+ OLs in the spinal cord of Padi2 cKO mice, compared to littermate controls ( Fig. 3a, b ). Nevertheless, we did not observe such an effect in the corpus callosum ( Fig. 3a ). This finding led us to further investigated if these OLs exhibited the same levels of OL-related genes by performing qPCR on the brains of P21 controls and Padi2 cKO. We observed that Pdgfra, Mbp and Mog mRNA were unaltered in FACS cKO GFP+ cells (Supplementary Fig. 2c ), indicating that the effect of Padi2 cKO is more prominent in posterior regions of the CNS. We also generated an inducible Padi2 cKO (indKO) mouse line, Pdgfra-CreERT; RCE:loxP; Padi2-/-, where Padi2 could be ablated from OPCs by tamoxifen treatment at early postnatal stages ( Fig. 3c ). Since we observed that PADI2 mainly modulates the transition between OPCs and NFOLs in vitro ( Fig. 2 ), we depleted Padi2 specifically at the onset of OPC differentiation by injecting mice with tamoxifen at P6 and collecting the brains and spinal cord at P11 ( Fig.  3c ). We show a reduction, although not statistically significant (p=0.0828 for corpus callosum and p=0,0567 for spinal cord), of OLs formed upon tamoxifen-induced OPC Padi2 depletion, as assessed by the percentage of CC1+ cells out of total GFP+ in the corpus callosum and in the spinal cord of Padi2 indKO animals, compared to littermate controls ( Fig.  3d ). Thus, our results in two independent mouse lines where Padi2 is ablated from the OPC stage suggest that PADI2 is important for the generation of OLs in vivo.
Padi2 knockout mice display impaired motor and cognitive functions, and a decrease in the number of myelinated axons. Given the decrease in OLs upon Padi2 cKO in the OL lineage and the targeting of myelin proteins by PADI2, we investigated whether Padi2 cKO mice presented a behavioral phenotype, in comparison with controls. Interestingly, Padi2 cKO mice exhibited impairment in motor coordination and balance as assessed by decreased latency to fall in the rotarod test ( Fig. 4a ). Moreover, we observed similar impairments in the full Padi2 KO (Padi2 fKO), where exon 1 of Padi2 is deleted in all cells 13 . In addition, we found an increase in the number of slips on the beam test in the Padi2 cKO mice, strengthening the motor impairment phenotype ( Fig. 4b ). Strikingly, when testing the Padi2 cKO mice for cognitive functions, these mice performed worse in the novel object recognition test, displaying a decrease in the discrimination index that provides an indication of recognition memory ( Fig. 4c ). To further investigate the mechanisms underlying the impact of PADI2 on motor and cognitive functions we have analyzed the myelin structure of the Padi2 fKO mice and respective controls by Electron Microcopy (EM). We found a significant decrease in the number of myelinated axons in the corpus callosum of adult mice together with a decrease in the g-ratio of small diameter axons and an increase in the g-ratio of axons with 0.6-0.9 µm diameter ( Fig. 4d-f ). Moreover, the percentage of myelinated axons was decreased in Padi2 fKO mice compared to controls ( Fig. 4g ). As such, our results indicate that PADI2 plays an important role for efficient OL differentiation and myelination, as evidenced by the motoric and cognitive defects occurring upon its ablation.
PADI2 is present in both nucleus and cytoplasm in OL lineage cells.
To disclose the possible mechanisms of action underlying the observed in vitro and in vivo effects, we have further investigated the cellular location of Padi2 in OL lineage cells. Despite that PADI4 is the only one displaying a nuclear localization signal (NLS), PADI2 has recently been detected in the nucleus of mammary epithelial cells 21 and was described to be able to citrullinate nuclear histone H3R26 in MC7 breast cancer cells 22 . Remarkably, immuno-cytochemistry analysis showed the presence of PADI2 protein both in the nucleus and in the cytoplasm of OPCs (MBPnegative) and OLs (MBP-positive) ( Fig. 5a ). In order to confirm the localization of PADI2 in the nucleus, we transfected Oli-neu cells with the fusion vector Padi2-ZsGreen. We observed the presence of the green fusion protein both in the nucleus and cytoplasm of these cells ( Fig. 5b ), indicating that PADI2 can indeed be nuclear in OL lineage cells and might thereby regulate transcription through epigenetic mechanisms.
PADI2 citrullinates nuclear proteins.
To determine what could be the molecular targets of PADI2 in both nuclei and cytoplasm, we generated a stable Padi2 overexpressing Olineu cell line, where citrullination activity was greatly enhanced when tested in an Antibody-based assay for PADI activity (ABAP) 23 ( Supplementary Figure 2a ), and performed quantitative proteomics, by applying stable isotope labeling of amino acids in cell culture (SILAC) followed by mass spectrometry 24 . SILAC relies on the incorporation of a light (12C) or a heavy (13C) isotopic version of lysine into proteins of control and overexpressing Padi2 cell lines, respectively. The proteomes of fully light (L) and heavily (H) labelled cells were mixed 1:1 and the relative dissimilarities in the proteome citrullination target sites of these cell populations was determined and quantified by mass spectrometry ( Fig. 5c ). Interestingly, we observed a striking difference in the number of citrullination targets and ratios between proliferating and differentiating Oli-neu cells (Fig. 5d ). In the proteome of proliferating Oli-neu, we found up to 151 citrullination sites, of which 81 were upregulated (H/L SILAC ratio higher than 1.5) with Padi2 overexpression. In contrast, up to 500 citrullination sites were identified in differentiating Oli-neu cells, of which 347 were upregulated upon Padi2 overexpression ( Fig. 5d and Supplementary Table 1 ). These observations indicate that OLs have an intracellular environment that is more permissive to PADI2 activity than OPCs.
We also uncovered citrullination sites arising only with Padi2 overexpression (no H/L SILAC ratio with peptides detected only in heavy proteomes; Fig. 5e and Supplementary Table 1). Consistent with our previous observations on the localization of PADI2 in the OL lineage ( Fig. 4a, b ), PADI2 targets were not only cytoplasmic such as ribosomal proteins and myelin proteins (for example HSPA8, CNP and RAB1, ENO1 and EEF1A25), but also nuclear ( Fig. 5e and Supplementary Table 1 ). Chromatin components and modulators such as histone H1 (HIST1H1B), histone H2b (HIST1H2BA), histone H3 (HIST1H3), the histone demethylase KDM3B and the chromodomain helicase DNA binding protein 6 (CHD6), among others, were identified to be cit-rullinated by PADI2 at specific arginines ( Fig. 5e ). We also observed citrullination of several RNA binding proteins, consistent with the abundance or arginines in their RNA binding motifs ( Fig. 5e ). Gene ontology (GO) analysis indicated that proteins citrullinated by PADI2 are involved in translation, ribosomal biogenesis and nucleosome assembly both in proliferating and differentiating conditions, and RNA splicing, RNA processing and posttranscriptional regulation of gene expression in differentiating conditions ( Fig. 5f and Supplementary Table 4 ). Thus, PADI2 activity is not circumscribed to myelin and cytoplasmic proteins but is also relevant to nuclear processes.
PADI2 protein-protein interaction network is enriched in cytoplasmic and myelin proteins. Our data suggests that PADI2 might be involved in different biological cell processes occurring both in the nucleus and in the cytoplasm. To further explore the PADI2 role in OL lineage cells, we identified the PADI2 protein interactors by pulling-down biotintagged PADI2. Control (expressing biotin ligase, BirA, and empty vector) and biotin-tagged Padi2 (bioPadi2) Oli-neu cell lines (expressing BirA and the biotin-tagged Padi2) were fed with 12C or 13C isotopes, respectively, immunoprecipitated with streptavidin beads and combined for further mass spectrometry analysis ( Fig. 6a ). As expected, PADI2 was the protein enriched the most (Fig. 6b ). We uncovered up to 74 shared PADI2 protein interactors in proliferating and 2-days differentiated Oli-neu cells (Fig. 6b , c, e and Supplementary Table 2 ), among which nuclear proteins such as elongator protein complex 1 (ELP1). Nevertheless, the number of interactors was much lower than citrullination targets, suggesting that most of the PADI2 interactions leading to citrullination are transient and cannot be captured. Yet, GO analysis on the biological processes showed common categories with the GO analysis of the PADI2 citrullination targets, such as translation and posttranscriptional regulation of gene expression ( Fig. 6d ), suggesting once again a role for PADI2 in these processes. Interestingly, one of the categories in the GO analysis, the intracellular protein transport, comprises RAN and KPNB1, two key regulators for active nuclear transport, which suggests that these proteins can be involved in the PADI2 nuclear-cytoplasmic shuttling (Supplementary Table  2 ). When performing GO analysis for the cellular component, we also have identified a myelin sheath component of PADI2 interactors (Fig. 6e , myelin sheath partners highlighted in red, Supplementary Table 4 ). Furthermore, comparison with a previously published myelin proteome 25 uncovers additional myelin proteins that interact with PADI2 such as WDR1, FASN, among others ( Fig. 6e and Supplementary Table 2 ). Thus, while interactions of PADI2 with nuclear proteins might be more transient, we observed several myelin proteins interacting with this enzyme.
Histone citrullination by PADI2 is associated with regulation of OL differentiation genes. Since we found PADI2 in the nucleus of OL lineage cells and identified sev-eral chromatin-associated proteins as targets of PADI2, we investigated whether citrullinated nuclear proteins, such as histones, are present in OL lineage cells, using an orthogonal technique. Indeed, western blot analysis of histone citrullination shows the presence of histone H3R26Cit and histone H3R2+8+17Cit in proliferating Oli-neu cells (Fig. 7a ). Treatment with 200 µM of the pan PADI inhibitors Cl-Amidine or 60 µM of 2-CA led to a reduction on these modifications (Fig.  7a ). We also observed an increase of histone H3R2+8+17Cit and Histone H3R26Cit in the Padi2 overexpressing cell lines indicating that PADI2 is mediating histone H3 citrullination and thus acts as an epigenetic regulator in OL lineage cells ( Fig. 7b ). While the expression of Mog and Sox9 was not altered upon Padi2 overexpression, we observed upregulation of Mbp and Cnp in differentiating cells ( Fig. 7c ), corroborating their downregulation upon PADI2 inhibition/Padi2 knockdown (Fig. 2) . Thus, histone citrullination might be one of the mechanisms by which PADI2 regulates the transition of OPCs to NFOLs.
Padi2 knockdown results in reduced accessibility at OL differentiation genes. To further examine the possible role of PADI2 in transcriptional regulation and the chromatin structure, we investigated if the knockdown of Padi2 would affect the chromatin accessibility. We performed assay for transposase-accessible chromatin using sequencing (ATACseq) 26 to identify changes in accessibility of regulatory regions in differentiating Oli-neu upon knockdown of Padi2 with siRNAs ( Fig. 7d ). Interestingly, we observed a general reduction in accessibility upon knock down of Padi2 ( Fig.  7d , Supplementary Fig. 2d and Supplementary Table 3 ). We further investigated accessibility of OL enhancers and promoters, presenting H3K27ac in Oli-neu cells (see methods) or H3K27ac/H3K4me3 in OPCs 27 . Indeed, we observed decreased chromatin accessibility in regulatory regions of genes as Pik3cd, Plin4 or Ezh1. Importantly, we also observed such reduction in accessibility in important regulators of OL myelination, including Sirt2, Mag and Mbp (Fig. 7d) , and in Plp1, Sox10 and Mog, although to minor extent (Supplementary Fig. 2d ). Accordingly, gene ontology analysis indicated an enrichment in regulatory regions of genes involved in lipid metabolism (Supplementary Fig. 2e and Supplementary Table 4 ). Nevertheless, PADI2 appears to target specific regulatory regions, since we did not find regulation of chromatin accessibility at regulatory regions of other genes modulating OL differentiation, such as Sox9, Tcf7l2, (Fig. 7d ), Id1 or Olig2 ( Supplementary Fig. 2d ). Interestingly, we also find a cohort of genes where accessibility of their regulatory regions was instead increased by Padi2 knockdown, including Cxcl2 (Fig. 7d ), Hspb8 or Gabra6. Gene ontology analysis indicated involvement in processes chemotaxis, Polycomb activity and apoptosis, among others ( Supplementary Fig. 2d and Supplementary Table 4 ). As such, recruitment of PADI2 to specific regulatory regions in OLs regulates their accessibility, which will also ultimately modulate transcriptional output, as observed for Mog and Sox10.
Discussion
The formation of myelin is a fundamental biological process that encompasses subsequent steps of OPC specification, differentiation and myelin sheath formation/wrapping of axons. Our study highlights PADI2 as an important player in these last two steps by 1) facilitating OPC differentiation and influencing the OL epigenetic landscape through histone citrullination and 2) interacting with and mediating the citrullination of several myelin protein components. While Padi2 expression in OLs and its occurrence in the myelin were described before 16 , we report for the first time its presence in OPCs and the dramatic upregulation of Padi2 in the transition from OPCs to NFOLs and its function facilitating OL lineage progression. To uncover PADI2 mechanisms of action, we further determined the citrullination targets and the binding partners of PADI2. Our data revealed new PADI2 citrullinated proteins and interactors, both located in the nuclear and cytoplasmic compartments. We also demonstrate, using 3 different Padi2 knockout mouse lines, that PADI2 is important for the OL development and motoric and cognitive behaviour. Our findings indicate that PADI2 mediated citrullination is required for efficient OL development with acting not only as a myelin modulator, through MBP citrullination, but also displaying other functions in the cytoplasm and nucleus, for instance as an epigenetic modulator. Additional mechanisms underlying PADI2 actions in OPC differentiation remain to be investigated.
By using an unbiased proteomics methodology based on SILAC followed by mass spectrometry we have revealed hundreds of novel citrullination protein targets and the respective arginine locations, some of those in core histones such as HIST1H1, HIST1H2 and HIST1H3. PADI2 mediated H3R26Cit has been shown to lead to local chromatin decondensation and targeted transcriptional activation in breast cancer cells 28 . In a similar manner, when we knockdown Padi2 we observe a general decrease in chromatin accessibility as revealed by ATAC-seq. Furthermore, upon PADIs inhibition or Padi2 knockdown we observed a decrease in the pro-differentiation and myelin genes such as Mbp, Mog and Sox10 suggesting that PADI2 might be locally enhancing transcription through histone H3 citrullination.
Interestingly, we detected HIST1H1C citrullination on R54 in our cells. This modification was previously described to induce global chromatin decondensation in iPS cells 5 and to be specifically mediated by PADI4, which suggests that there is an overlap of the substrates of PADI2 and PADI4. Moreover, H3R2+8+17Cit was also induced upon hPadi4 overexpression 5 . hPADI2 and hPADI4 were shown to exhibit different substrate preferences and hPADI4 had more pronounced substrate specificity, in both Cos-1 and HEK cells or by adding recombinant hPADIs to cell lysates 29 . Additional hPADI2 targets were disclosed by overexpressing hPADI2 in HEK cells using a different technology 30 . Although these are targets for hPADI2 in different human cell types, we observed many common targets with our mouse OL lineage cells such as ribosomal proteins and splicing factors. Thus, PADI2 might have a widespread and undetermined role in basic cellular processes such as mRNA splicing and translation.
Differentiated Oli-neu cells displayed considerably more citrullination targets, higher citrullination activity in basal conditions with the ABAP kit, and a more pronounced increase in H3R2+8+17Cit and H3R26Cit upon Padi2 overexpression suggesting that PADI2 activity can be enhanced upon differentiation. In agreement, most of PADI2 effects are more noticeable upon OPC differentiation. Of notice, PADI activity can also be context dependent, as these enzymes need a high concentration of calcium to become active, and calcium signaling has been shown to be fundamental for OPC migration, differentiation and myelination 31 . Although several citrullination targets found in proliferating and 2-days differentiated Oli-neu were common and/or showed additional citrullinated arginine in differentiation, they did not overlap completely, indicating that there is a preference for the targeted arginine between these conditions that could be due for instance, to differences in the binding partners. Likewise, not all proteins found interacting with PADI2 were citrullinated and vice versa. Nevertheless, GO analysis for the biological processes on the PADI2 interactors also reveals categories similar to the citrullination targets, such as translation and posttranscriptional regulation of gene expression reinforcing once again a putative role for PADI2 in these processes. Mice overexpressing Padi2 under the Mbp promoter display abnormal myelination with structural changes of the myelin 10 . This effect was attributed to the increased citrullination of MBP and also of histones that would ultimately cause OL apoptosis 10 . However, a striking finding in our study is the abundance of myelin component proteins within the interactors of PADI2, that might also mediate the effect of PADI2 on myelin when overexpressed 10 . Citrullination of myelin proteins is naturally occurring, and thus normal citrullination levels must certainly have a physiological function. 2',3'-Cyclic-nucleotide 3'-phosphodiesterase (CNP), which has an important role in the generation of cytoplasmic channels in OLs 32 , displayed PADI2-mediated citrullination of several arginines (Table S1 ). It is possible that hypocitrullination of CNP upon knocking out PADI2 could lead to disruption of cytoplasmic channels and ultimately to the observed defects on myelination in our Padi2 fKO mice ( Fig. 7) . Further investigation would be necessary to determine which citrullination targets of PADI2 in the myelin could be responsible for these defects. We found that PADI2 absence in OL lineage cells caused decreased OL cell density in spinal cord and a decrease in the number of myelinated axons in the corpus callosum of adult mice, that were reflected in motor and cognitive dysfunctions. Since Pdgfra and Padi2 can also be co-expressed in other non-CNS cells such as Schwann cells, the impairment on motor functions could also be due to the absence of PADI2 in peripheral cells. However, overexpression of Padi2 did not have any effect on the peripheral myelin 10 and the EM and OL densities analysis in the brain and spinal cord (Fig. 7) indicate a phenotype in OLs. In addition, the cognitive behavior test also supports a CNS specific PADI2 effect. Analysis of single-cell RNA-Seq data ( Supplementary Fig.  1 ) suggested that PADI2 is the only member of the PADI family robustly expressed in the OL lineage. Although PADI4 was identified by IHC in the myelin 16 we could not detect Padi4 mRNA in any OL lineage cell tested nor it was identified in the myelin proteome 25 . However, we did detect very low mRNA levels of Padi3 and Padi1 in Oli-neu cells and found it expressed in very few cells in OPCs/OLs collected from P90 brains (data not shown). As such, we cannot totally rule out that these PADIs have a function in OL lineage progression and that compensatory mechanisms might be operational upon PADI2 knockdown, knockout or inhibition, particularly since PADIs can have overlapping substrates. PADI2 has been long investigated in the context of MS since MBP hypercitrullination is a hallmark of the disease 33 . Our study demonstrates that PADI2-mediated citrullination is also required for OL lineage progression and myelination and uncovers several new citrullination targets in the OL lineage. Thus, targeted activation of PADI2 in the OL lineage might be beneficial in the context of remyelination in diseases as multiple sclerosis.
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Experimental procedures
Animals. All mice were maintained under a pathogen-free environment at the animal facility. All experimental procedures were performed following the guidelines and recommendations of local animal protection legislation and were approved by the local committee for ethical experiments on laboratory animals (Stockholms Norra Djurförsöksetiska nämnd in Sweden). The following transgenic mice strains were used: Pdgfra-H2BGFP knock-in mice 17 
Behavioral analysis.
For the beam balance test the fine motor coordination and balance was assessed by beam walking assay. Performance on the beam was quantified by measuring the time taken by the mouse to traverse the beam and the number of paw slips that occurred in the process. The beam apparatus consisted of a PVC plastic beam (1.2 cm wide × 100 cm long) located 50 cm above the table top on two poles. A black box was placed at the end of the beam as the finish point. Nesting material and faeces from home cages was placed in the black box to attract the mouse to the finish point. A nylon or cotton pad was placed below the beam, to cushion any falls. Mice were trained three times a day for two consecutive days until they were able to cross the beam without hesitation. No data were collected during these sessions. During the test session, the time needed to cross the beam and the number of paw slips were recorded. The beam and box were cleaned of mouse droppings and wiped with 70% ethanol before the next animal was placed on the apparatus. The novel object recognition task was conducted as described previously 34 , and was used to assess the nonspatial hippocampal memory. A mouse was presented with two similar objects during the first session, and then one of the two objects was replaced by a new object during a second session. The amount of time taken to explore the new object provided the index of recognition memory. The task consisted of habituation, training, and testing phases conducted on separate days. During habituation, mice were allowed to freely explore an empty white box (60 cm wide × 60 cm long × 47 cm high) for 5 min/day for two days. Twenty-four hours later, mice were re-habituated (familiarization session) in the same box for 10 min, with two identical objects placed inside, 5 cm away from the walls. Mice were allowed to freely investigate until they accumulated a total of 20 sec exploring the objects. Exploration and recognition of the object were determined when the nose of the animal was in contact with an object or directing nose to the object within a defined distance (<2 cm). Mice were then immediately returned to their home cage. After the familiarization session, the objects and the open field was cleaned with 70% ethanol to minimize olfactory cues. After 1 hour of familiarization session, object recognition was tested, using the same procedure as in training except that one of the familiar objects was substituted with a novel object (cleaned and free of olfactory cues). The position of the novel object (left or right) has to be randomized between each mouse and each group tested. Time spent with each object was recorded using a stopwatch by a trained observer. Mice inherently prefer to explore novel objects; thus, a preference for the novel object indicates intact memory for the familiar object. A discrimination index was calculated according to the following formula: time of novel object exploration/time of novel plus familiar object explo-ration×100. Rotarod behavioral analysis was performed for evaluation of coordination and motor learning. Mice were trained on a Rotarod (Ugo Basile, Comerio VA, Italy) at a constant speed (4 rpm), 120 s per day for 3 consecutive days. Subsequently, test day consisted of three trials on an accelerating rotarod for up to 300 s (starting at 4 rpm accelerating to a final speed of 40 rpm), with mice returned to their home cages for at least 30 min between trials. The time at which each animal fell from the rod was recorded as a measure of motor coordination and repeated measurements of speed at the time of animal falling were averaged. 35, 36 ). The following day (after overnight post-fixation), an additional fixation step was carried out using 2% osmium tetroxide in 0.1M PBS (pH 7.4), after which samples were dehydrated in a graded series of ethyl alcohol. Finally, samples were embedded using Durcupan resin in between two pieces of ACLAR sheets (Electron Microscopy Sciences). Ultrathin sections of 80nm were obtained using a Lecia EM UC7 ultramicrotome and placed on formvar coated slot copper grids (Electron Microscopy Sciences). Uranyl acetate and lead citrate counterstained samples were viewed under a FEI Tecnai12 BioTwinG2 electron microscope. Digital images (minimum 10 per animal, taken at 11,000x) were acquired using an AMT XR-60 CCD Digital Camera system and compiled using Abobe Photoshop software. G-ratio was determined by dividing the mean axon diameter without myelin by the same axon diameter with myelin. A minimum of 100 healthy axons were considered per animal. To determine the size distribution of myelinated fibers in corpus callosum, diameters of all measured axons were separated into four ranges (0.3-0.6, 0.6-0.9, 0.9-1.2, & >1.2 µm). No axons with diameters smaller than 0.3 µm were considered. Data are expressed as comparison of means between the control and knock-out for each range. Percentage of myelinated axons was determined by placing a centered grid over the image using ImageJ software, and counting whether the axon at each intersection was myelinated or not. A minimum of 100 axons was counted per image, and 10 images were quantified per animal. All measurements were acquired on electron microscopy sections images using an ImageJ software. Mann-Whitney U tests were performed to assess statistical differences between control and knock out mice for both differences in g-ratio per axon diameter range and percent myelinated axons.
Tissue dissociation. Cells were isolated from postnatal, juvenile and adult brains from Pdgfra-Cre;RCE:loxP mice, and from juvenile brains from Pdgfra-Cre;RCE:loxP;Padi2+/+ and PdgfraCre;RCE:loxP;Padi2fl/fl mice with Neural (for postnatal) and Adult (for juvenile and adult) Tissue Dissociation kits (P) (Miltenyi Biotec). Cell suspensions were then filtered with 30µm filter (Partec) and FACS sorted for selection of GFP+. FACS sorted cells were collected in eppendorf tubes, centrifuged at 400xg, resuspended in Qiazol and frozen for further RNA extraction/cDNA synthesis.
FACS. GFP+cells were FACS sorted using a BD FACSAria III Cell Sorter B5/R3/V3 system. Cells were collected either in PBS for further RNA extraction processing or in OPC media directly into coated plates. For OPC removal on OL lineage cells from juvenile and adult brains, CD140 (anti-mouse CD140 APC conjugated, BD Bioscience) labelling was performed in tissue-isolated cells and GFP+CD140+ cells were excluded. To define the gates for specific CD140+ cells we have performed an additional labelling with APC conjugated IgG (BD Bioscience) as a negative control.
Cell culture. Primary OPC culture: GFP+ OPCs were obtained with FACS from P1-P4 brains from the Pdgfra-H2BGFP mouse line. The mouse brains were removed and dissociated in single cell suspensions using the Neural Tissue Dissociation Kit (P) (Miltenyi Biotec, 130-092-628) according to the manufacturer's protocol. Cells were seeded in poly-L-lysine (O/N) (Sigma P4707) plus fibronectin (1h) (Sigma F1141) coated dishes and grown in proliferation media comprising DMEM/Gmax (life tec 10565018), N2 media (life tec 17502048), Pen/Strep (life tec 15140122), NeuroBrew (Miltenyi 130-093-566), bFGF 20ng/ml (Peprotech 100-18B) and PDGF-AA 10ng/ml (R&D 520-BB-050). For OPC differentiation, cells were left for 2 days in medium without bFGF and PDGF-AA. Oli-neu cell culture: Oli-neu cells were grown in poly-L-lysine coated dishes and expanded in proliferation media consisting of DMEM (life tec 41965062), N2 supplement, Pen/Strep Glu (life tec 10378016), T3 (sigma T6397) 340ng/ml, L-thyroxine (sigma 89430) 400 ng/ml, bFGF 10ng/ml and Pdgf-BB 1ng/ml. For Oli-neu differentiation, media without growth factors was added for two days in vitro and in the presence of 1µM of erb inhibitor (PD174265, St Cruz,sc-204170). Rat OPC cultures: primary rat OPCs were isolated as reported previously 37 . Briefly, mixed glia cultures were first derived from rat brain cortex at postnatal day 1. OPCs were selected by the A2B5 antibody followed by purification with the magnetic rat anti-mouse IgM beads (Miltenyi Biotec). Purified OPCs were cultured in the SATO medium supplemented with PDGFA and bFGF, and were induced to differentiate with T3 replacing the growth factors. PADI inhibition: Olineu cells were treated either with Cl-Amidine (Millipore 506282) or 2-chloroacetamidine (2CA) (Sigma C0267) at a concentration of 200 µM and 60 µM for one and two days, respectively, in proliferation and differentiation media.
SILAC.
To generate LIGHT and HEAVY labeled cell lines, Oli-neu cells were grown and expanded in LIGHT (Lysine 12C) or HEAVY (Lysine 13C) media for at least five passages. The media was prepared with SILAC Advanced DMEM/F12-FLEX kit (Life Tec, MS10033) and contained 0.1% of dialyzed FBS, 10ng/ml bFGF, 10ng/ml PDGF-BB, 400ng/ml of L-thyroxine and 340ng/ml of T3. For the differentiation, growth factors and the FBS were removed. LIGHT labeled cells lines correspond to all controls, scramble overexpression control and BirA control, while HEAVY labeled cell lines comprise the overexpression of Padi2 or the biotin tagged Padi2. A control experiment in which control cells were also fed with heavy media and then mixed 1:1 with light control cells was performed in order to confirm that all proteins in heavy conditions were heavily labeled (Supplementary Fig. 2b ).
Padi2 overexpression cell lines and knock down. Padi2
and Ctr overexpression cell lines were generated by insertion of the following vectors with piggyBac transposon system: pB-CAG-Ctr, pB-CAG-Padi2 and for the control and overexpression of Padi2, respectively; pB-CAG-BirA together with pB-CAG-IRES-GFP as a control and pB-CAG-BirA together with pB-CAG-bioPadi2-IRES-GFP for the biotin tagged Padi2. The gateway system was used to clone all these vectors (Gateway® LR Clonase® II Enzyme mix, 11791020 and Gateway® BP Clonase® II En-zyme mix11789020) in Oli-neu cells. pB-CAG-Ctr, pB-CAG-Padi2, pB-CAG-BirA + pB-CAG-IRES-GFP and pB-CAG-BirA + pB-CAG-bioPadi2-IRES-GFP were transfected together with piggyBac transposase (pBase) expression vector by lipofection according to the manufacturer's instructions (Lipofectamine® 2000, Invitrogen 11668019). To select for biotin tagged Padi2 and pB-CAG-IRES-GFP vectors cells were FACsorted for GFP, all the other cell lines express the hygromycin resistance gene in the DNA integrated vectors and were selected and expanded in media containing 200 µg/ml of hygromycin. For the expression of the fusion Padi2 plasmid in Oli-neu OPCs, Padi2 was cloned into the pZsGreen1-N1 plasmid (Clontech, 632448). Oli-neu and primary mouse OPCs were then transfected with these plasmids with Lipofectamine2000 according to the manufacturer's instructions. For silencing Padi2 we used the siDESIGN center from Dharmacon. The following siRNAs were selected and purchased from Dharmacon GE Healthcare: mouse Padi2; sense: 5' CGUACGUGAUGGAGAGGCAUU 3'; antisense: 5' UGCCUCUCCAUCACGUACGUU 3' and ON-TARGETplus Non-targeting siRNA #1 (D-001810-01-20). Knockdown experiments for Padi2 were performed both in Oli-neu and mouse primary OPCs with Lipofectamine2000, following manufacturer's instructions. For mouse primary OPCs, upon 4h of adding the lipids:DNA complexes to the cells, media was changed to either proliferation or differentiation and cells were collected two days after. For Oli-neu experiments, upon 4h of adding the lipids:DNA complexes to the cells, media was changed to proliferation for one day and cells were either collected at this point (proliferation condition) or changed to differentiation media one more day (differentiation condition). was used according to the manufacturer's instructions, each PCR reaction had a final volume of 10µl and 1-2.5µl of diluted cDNA and RT-. The running conditions were 20 seconds at 95 • C, followed by 40 cycles of 3 seconds of 95 • C and 30 seconds of 60 • C, then 15 seconds at 95 • C, 1 minute at 60 • C and 15 seconds at 95 • C. A melting curve was obtained for each PCR product after each run, to control for primer dimers and gene-specific peaks. Random PCR products were also run in a 2-3% agarose gel to verify the size of the amplicon. Tbp and Gapdh were run as housekeeping genes. Relative standard curves were generated for each gene to determine relative expression (CT values are converted to were added and solutions were mixed thoroughly before isolating the DNA with Maxitract High Density Tubes (Qiagen). 2.5 Volumes of 100% ethanol and 1/10 volume of 3M NaOAc (Sigma) were added to the sample and incubated for 15 min at -80 • C. DNA was washed with 70% ethanol and resuspended in nuclease free water.
ABAP. Cells were collected in lysis buffer
ATAC-seq. ATAC-seq was performed as previously described 26 with minor adaptations. Oli-neu cells (differentiated, siRNA treated as described above) were collected with Accutase solution (Sigma-Aldrich, A6964). 50 000 cells per condition were lysed in lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.1% IGEPAL CA-630) and centrifuged at 500xg at 4°C for 20 minutes. The cells were then resuspended in tagmentation mix (2.5 µl TD buffer, 2.5 µl Tn5 enzyme, Illumina) and the DNA was transposed for 30 minutes at 37°C, where after the DNA was purified using the Qiagen MinElute kit. After PCR amplification with 7-8 cycles (cycles determined with qPCR) the libraries were sequenced on a HiSeq2500 Illumina sequencer. Three replicates per condition were performed in different days and different passages. Each replicate had > 10 million reads with an average of 45 million reads per sample.
Bioinformatic analysis of ChIP-seq and ATAC-seq. siPadi2 ATAC-seq processing. ATAC-seq siCtrl and siPadi2 replicates were processed separately following the standard ENCODE pipeline for ATAC-seq samples, https://www.encodeproject.org/pipelines/ENCPL792NWO/. Adapters were detected and trimmed with cutadapt 1.9.1 46 and aligned to mouse genome (GRCm38/mm10) using Bowtie2 47 , with default parameters. After filtering mitochondrial DNA, reads properly paired were retained and multimapped reads, with MAPQ < 30, were removed using SAMtools 48 . PCR duplicates were removed using MarkDuplicates (Picard -latest version 1.126), http://broadinstitute.github.io/picard/. ATAC-seq peaks were called using MACS2 https://github.com/taoliu/MACS/ 49 , with parameters -g mm -q 0.05 -nomodel -shift -100 -extsize 200 -B -broad. To get the consensus promoter/enhancer regions from each of the replicates we first selected the significant peaks -log10(p-value) > 1.30103. Using bedtools.2.17 mergeBed, we recovered the consensus ATAC peak region that included more than one replicate for siCtrl samples and siPadi2 samples. From where we recovered 76021 and 55772 union peaks regions for siCtrl and siPadi2, respectively. For visualization and further analyses, the different replicates were merged using Samtools and tracks were normalized using deeptools bamcoverage, normalized with RPKM.
H3K27ac ChIP-seq data. Raw reads were mapped to the mouse genome (GRCm38/mm10) with Bowtie 2.1.0 47 . Uniquely mapped reads (17 and 19.5 million for proliferation and differentiation chromatin samples) were then processed with SAMTools for format conversion and removal of PCR duplicates 48 . Broad peaks corresponding to H3K27ac enrichment were called using MACS 2.0.10, with q-value cutoff at 5*10-249. H3K27ac peaks were filtered against blacklisted genomic regions prone to artifacts (ENCODE Project Consortium, 2012) with BEDTools 50 and annotated to the nearest Transcription Start Site with PeakAnalyzer 51 .
Defined promoter/enhancer regions. We recovered the regions around the transcription start site (TSS) from gene annotations, ENSEMBL83. The putative promoter regions were extracted as -3KB upstream the TSS and 100bp downtream the TSS, to recover possible promoter and enhancer regions. To get more reliable signal we intersected the siCtrl union peaks with peaks from H3K27ac ChIP-Seq in Olineu cells in differentiation and proliferation conditions (see above), ending with 17281 siCtrl/promoter peaks overlapping with H3K27ac peaks. Only the union peaks (7087 peaks) from siCtrl/H3K27ac overlapping the defined promoter regions were retained, using Bedtools intersect 50 . In order to recover possible enhancer and promoter regions that could be have been excluded from H3K27ac filtering or due to been more downstream of defined promoter regions, we included in the analysis a known mark of promoters/enhancers, H3K4me3 in OPC-like cells (GSE80089) 27 . We recovered the peaks bed file of H3K4me3 control peaks, 
